Universal Corp (UVV) 2023 Q2 法說會逐字稿

Hello, all. Thank you for your patience, and a warm welcome to Universal Corporation Second Quarter Fiscal Year 2023 Earnings Call. My name is Luisa, and I'll be your operator today. (Operator Instructions)

And now I have the pleasure to turn the call today to Candace Formacek, Vice President and Treasurer at Universal Corporation. Candace, please go ahead.

Thank you, Luisa. Thank you all for joining us. George Freeman, our Chairman, President and CEO; Airton Hentschke, our Chief Operating Officer; and Johan Kroner, our Chief Financial Officer are here with me today and will join me in answering questions after these brief remarks.

This call is being webcast live and will be available on our website and on telephone taped replay. It will remain on our website through February 3, 2023. Other than the replay, we have not authorized and disclaim responsibility for any recording, replay or distribution of any transcription of this call. This call is copyrighted and may not be used without our permission.

Before I begin to discuss our results, I caution you that we will be making forward-looking statements that are based on our current knowledge and some assumptions about the future and are representative as of today only. Actual results could differ materially from projected or estimated results, and we assume no obligation to update any forward-looking statements. This is a particular note during the current ongoing COVID pandemic when the length and severity of the crisis and resultant economic and business impacts are so difficult to predict.

For information on some of the factors that can affect our estimates, I urge you to read our 10-K for the year ended March 31, 2022, as well as our Form 10-Q for the quarter ended September 30, 2022. Such risks and uncertainties include, but are not limited to, the ongoing COVID-19 pandemic, customer-mandated timing of shipments, weather conditions, political and economic environment, government regulation and taxation, changes in exchange rates and interest rates, industry consolidation and evolution and changes in market structure or sources.

Finally, some of the information I have for you today is based on unaudited allocations and is subject to reclassification. In an effort to provide useful information to our investors, our comments today may include non-GAAP financial measures. For detail on these measures, including reconciliations to the most comparable GAAP measures, please refer to our current earnings press release.

Moving to the quarter. Demand for both our tobacco and plant-based ingredients products remain very strong, and we are excited about how our fiscal year 2023 is developing. We are seeing improvement in shipping availability, particularly in Brazil where we're able to shift large amounts of carryover tobacco in both the 6 months and quarter ended September 30, 2022. We also remain very pleased with our strategic investment in our plant-based ingredients platform. Our Ingredients Operations, diversifies our earnings and delivered higher results driven by higher sales in both the 6 months and quarter ended September 30, 2022, compared to the same periods in the prior fiscal year.

We believe we are through our peak seasonal working capital requirements for fiscal year 2023, and we expect a considerable reduction in debt levels over the next 2 fiscal quarters. We have already seen significant working capital receipts in October 2022. Our tobacco shipments, which are weighted to the second half of our fiscal year, should enable us to reduce our debt levels from the elevated September 30, 2022, levels as payments are received from our customers.

Operating income for our tobacco operations segment for the 6 months and quarter ended September 30, 2022, was up significantly compared to the comparable periods in the prior fiscal year, driven by increased tobacco shipments.

Improved container and vessel availability in Brazil enabled us to ship a greater amount of tobacco, particularly in the second fiscal quarter. A large portion of the tobacco we shipped during the 6 months and quarter ended September 30, 2022, was carryover tobacco, and some tobacco we shipped with lower margin tobacco. While we are still having some shipping challenges in certain areas around the world, we are encouraged by the global easing of shipping constraints.

All types of leaf tobacco are currently in an undersupply position. We have worked diligently to secure the leaf tobacco desired by our customers, and our tobacco inventories were nearly 90% committed for sale to our customers at September 30, 2022. Early tobacco crops have been particularly short in Africa, largely due to weather conditions, which has limited our sales opportunities there.

Our Ingredients Operations segment again delivered healthy results in the 6 months and quarter ended September 30, 2022. Demand for our ingredients products remain strong, and we continue to capitalize on synergies across the plant-based ingredients platform. We have seen inflationary cost increases, particularly for raw materials and labor, but margins have held up nicely. As these businesses continue to find success with their established products, we are working to grow the platform offerings by investing in key sales and product development personnel to promote and expand the full range of our ingredients capabilities across the platform.

Net income turning to results. The net income for the 6 months ended September 30, 2022, was $28.7 million or $1.15 per diluted share compared with $25.9 million or $1.04 per diluted share for the 6 months ended September 30, 2021. Excluding restructuring and impairment costs and certain other nonrecurring items detailed in other items in today's earnings release, net income and diluted earnings per share increased by $4.1 million and $0.17, respectively, for the 6 months ended September 30, 2022, compared to the 6 months ended September 30, 2021.

Adjusted operating income also detailed in today's earnings release of $51.2 million increased by $9.5 million for the first half of fiscal year 2023 compared to adjusted operating income of $41.6 million for the first half of fiscal year 2022.

Net income for the quarter ended September 30, 2022, was $21.9 million or $0.88 per diluted share compared with $19.5 million or $0.78 per diluted share for the quarter ended September 30, 2021. Excluding restructuring and impairment costs and certain other nonrecurring items detailed in other items in today's earnings release, net income and diluted earnings per share increased by $5.3 million and $0.22, respectively, for the quarter ended September 30, 2022, compared to the quarter ended September 30, 2021.

Adjusted operating income also detailed in today's earnings release of $37.9 million increased by $8.9 million for the second quarter of fiscal year 2023 compared to adjusted operating income of $29 million for the second quarter of fiscal year 2022.

Consolidated revenues increased by $276.8 million to $1.1 billion and by $197 million to $651 million, respectively, for the 6 months and quarter ended September 30, 2022, compared to the same periods in fiscal year 2022 on higher tobacco sales volumes and prices as well as the addition of the business acquired in October 2021 in the Ingredients Operations segment.

Turning to the segment detail. Operating income for the Tobacco Operations segment increased by $6.1 million to $41.9 million and by $6.9 million to $33.8 million, respectively, for the 6 months and quarter ended September 30, 2022, compared to the same periods in the prior fiscal year. Tobacco Operations segment results improved largely due to substantial shipments of both carryover and current crop tobacco. While sales volumes were higher in the Tobacco Operations segment in the 6 months and quarter ended September 30, 2022, compared to the same periods in the prior fiscal year, the sales included some lower-margin tobacco.

Unfavorable foreign currency comparisons due to the strong U.S. dollar also negatively impacted Tobacco Operations segment results in the 6 months and quarter ended September 30, 2022. Carryover and current crop tobacco shipments from Brazil were up significantly in the 6 months and quarter ended September 30, 2022, compared to the same period last fiscal year. While in Africa, carryover and current crop shipments from Mozambique and Malawi were lower in the 6 months and quarter ended September 30, 2022, compared to the same periods in fiscal year 2022 due to smaller crop sizes as well as some logistical delays.

In North America, sales volumes were down, in part due to shipment timing. And the sales mix included some lower-margin tobacco in the 6 months and quarter ended September 30, 2022, compared to the same period in fiscal year 2022.

Trading business was up in Asia in the first half of fiscal year 2023 compared to the first half of fiscal year 2022. Selling, general and administrative expenses for the Tobacco Operations segment were higher in the 6 months and quarter ended September 30, 2022, compared to the 6 months and quarter ended September 30, 2021, primarily due to unfavorable foreign currency comparisons.

Operating income for the Ingredients Operations segment was $9.1 million and $4.5 million, respectively, for the 6 months and quarter ended September 30, 2022, compared to $7.1 million and $2.7 million, respectively, for the 6 months and quarter ended September 30, 2021. Results for the Ingredients segment improved compared to the same periods in the prior fiscal year on the inclusion of the October 2021 purchase of Shank's Extracts, LLC.

For both the 6 months and quarter ended September 30, 2021, the Ingredients Operations segment continued to see strong demand and volumes in both human and pet food category. Despite higher costs for raw materials, labor, travel and marketing, margins for the Ingredients Operations segment in the first half of fiscal year 2023 continue to hold up well compared to those in the first half of fiscal year 2022. Selling, general and administrative expenses for the segment increased in the 6 months and quarter ended September 30, 2022, compared to the same periods in the prior fiscal year, primarily on the addition of Shank's.

Moving forward, Universal remains focused on integrating sustainability into all aspects of our business. A key part of our sustainability efforts is reducing global emissions. To support us in developing our long-term strategy for reducing our global emissions footprint, we have engaged with third parties to develop a low-carbon transition plan and to prepare for updated guidance on meeting future net zero targets.

At this time, we are available to take your questions.

(Operator Instructions) Our first telephone question comes from Ann Gurkin of Davenport.

Congratulations on nice results. I just want to start with big picture question, looking at your investor presentation on Slide 26, where you outlined progression of revenues and then a 3-year average operating income number. What would it take to get back to that 3-year average operating income number, which I think is around $200 million? What are the key drivers we should look for? Can you return to that number?

Ann, again, in this current environment, I believe that supply and demand, we are certainly in a shortage of supply. But as we called out in the press release, margins are holding up really nicely. So it's all about, can we get the volume to reach these numbers? But everything looks really positive at the moment for the year.

Okay. So it looks like if you increase tobacco, volume will help drive you back to that 3-year average number if that crop size has increased.

Well, the crop size is...

It's your margin, right? Yes.

We're a bit down. But yes, based on what we're seeing, we should be able to achieve those yet.

Okay. Great. And then in terms of the ingredient operating margin, is it still possible to hit high single digits for the full year?

Well, the thing that we told you previously, Ann, is we -- especially with Silva, they are sitting on a fairly large amount of inventory. That's their operating model. And some of that inventory that they have in inventory right now, as we have pointed out in previous calls, was brought in with fairly high shipping costs. So those margins have held up nicely better than we had anticipated. So whether or not they hit exactly those numbers that you're talking about, we just don't know yet, but it looks really positive for the year.

Okay. Great. And then you highlighted that you're adding or investing in salespeople and development folks and opportunities. Is that something you will do organically? Or will you need to do M&A to fill in white spaces? And what is the current capacity utilization of your existing ingredient offering?

We build some of those positions by a few outside hires.

Yes. So -- but the intention certainly is, Ann, that we will grow both organically as well as through acquisitions going forward. We have made these 3 acquisitions. They are working extremely well. We're really pleased with how it's developing. There clearly are synergies to be had in the existing platform as it stands. So we will go both ways and we are hiring some folks in order to just achieve the goals that we have set for ourselves.

And then in terms of development, you will -- you have opportunities to leverage the platforms you have as well as maybe make some tuck-in acquisitions or add some additional product lines.

The tuck-in acquisitions at this point in time with the debt levels we have, that certainly is we have put a pause on those, but we were certainly looking at other things that we can do organically where we can grow, where we can add. We have capacity, but we -- certain capabilities are just not there yet. So we're looking at those types of things going forward.

Okay. Great. And then capacity utilization at your current processing plant. Do you have room to add, additional sales volume?

It differs across the platform. Some of them are close to capacity on certain products and others are -- might be at 50%. It all depends on where we're looking and what we're looking for. We certainly are trying to fill that capacity with all our products, and we are successful in some of those efforts.

Okay. Great. And then are you getting ready to prices again going into calendar '23 for the Ingredients business?

That all depends on which products you're talking about. Some of the products that we are looking at have probably reached a level that they are coming slightly back down. We are seeing some longer crops in apples, so those prices seem to come down. But in others, it all depends that some of the stuff that is coming out of some of the other origins, it all depends. Energy prices and all these other things remains to be seen. We're contracting that at this point in time, and we're talking to customers about that at this point in time.

Okay. And then switching to tobacco customers talking about -- moving into noncombustible tobacco offering. So how do you position Universal to participate in the customer movements or focus on noncombustible tobacco offerings?

Yes, today, Ann, we have a portfolio of products and services that we participate on the combustible and the noncombustible. We have 2 sheet operations in Europe where we do supply services and products for these new generation products. And we also have the AmeriNic that continue developing for the vaping industry. So those are the areas that we are positioned today with raw material for combustible and noncombustible and services for the new generation products.

Okay. And then in this world of rising interest rates, what percentage of your debt is fixed or your reliance of credit or fixed? Or how do I think about interest expense over the next 12 to 18 months for you?

Well, we actually swapped some of that, which is in the K. So you can look up that number in the K. The debt levels, of course, are significantly higher than what we like, but we like to keep a fairly large portion of it variable because then that works better for our -- the way we work.

So the interest expense we see in the quarter is something we carry forward? Or should that move it higher?

Keep in mind that the balances are fairly high. So we certainly expect considerable decreases in those balances in the latter part of this fiscal year.

Okay. SG&A expense, which you talked about a little bit on the call was ahead of what I was expecting. I was using more of a run rate that we saw last quarter. So should I think of it more of the run rate as what we saw this latest quarter, given currency in those numbers?

Well, again, there were certainly inflationary increases. We saw some increases in travel and those type of things for sure. The big driver certainly for this quarter versus last year was certainly Shank's as well as the negative variance with regard to the FX, the currency -- the negative currency comparison. Strong dollar has an impact on that.

Okay. And then nice to see the Board approved the share repurchase program, but are you all ever going to buy back stock?

When we have excess cash, Ann, we will certainly be thinking about it.

Okay. And then Candace, the worldwide uncommitted lease inventory number. I always get that.

Yes. I think it's the same as reported previously. But just to be clear, that's 49 million kilos as of 6/30/22, which is down 13 million kilos from 3/31/22. So that should be about the same as we gave you before, nothing new this quarter.

(Operator Instructions) It seems we have no current questions. So I'd like to turn the call back to Candace Formacek and the team for any final remarks. Thank you.

Thank you, Luisa, and thank you all for joining us today. We'll be talking with you again next quarter. Good evening.

Good night.

Thank you all for joining today's call. You may now disconnect, and have a good day.